Background: The achievements in combating the increasing trend of overweight and obesity have thus far been inadequate. The recently discovered instrumental role of the gut microbiota in host metabolism may offer a novel target in the prevention and management of obesity. Objective: To evaluate the impact of perinatal probiotic intervention on childhood growth patterns and the development of overweight during a 10-year follow-up. Patients and methods: Altogether 159 women were randomized and double-blinded to receive probiotics (1 Â 10 10 colonyforming units of Lactobacillus rhamnosus GG, ATCC 53103) or placebo 4 weeks before expected delivery; the intervention extending for 6 months postnatally. Anthropometric measurements of the children were taken at the ages of 3, 6, 12 and 24 months and at 4, 7 and 10 years in 113 (72%) children. Results: The excessive weight gain was detected to be two-parted; the initial phase of excessive weight gain initiating during fetal period and continuing until 24-48 months of age and a second phase of excessive weight gain starting after the age of 24-48 months. The perinatal probiotic intervention appeared to moderate the initial phase of excessive weight gain, especially among children who later became overweight, but not the second phase of excessive weight gain, the impact being most pronounced at the age of 4 years (P ¼ 0.063, analysis of variance for repeated measures). The effect of intervention was also shown as a tendency to reduce the birth-weight-adjusted mean body mass index at the age of 4 years (P ¼ 0.080, analysis of covariance). Conclusions: Early gut microbiota modulation with probiotics may modify the growth pattern of the child by restraining excessive weight gain during the first years of life. This novel observation calls for further epidemiological and clinical trials, with precise data on early growth patterns and on confounding factors influencing weight development.
Introduction
Obesity with its comorbidities can currently be considered as a major threat to the health and wellbeing of humankind. 1 In particular, the increasing incidence of obesity in children 2 is a source of concern, in that it is likely to persist to adulthood. 3 Epidemiological data point to high birth weight on the one hand 4, 5 or faster postnatal growth on the other [6] [7] [8] [9] as the initial requisite for later obesity. Nonetheless, the most critical and sensitive period of childhood growth and the underlying denominators for obesity remain elusive. A recent hypothesis envisages the gut microbiota as instrumental in the control of bodyweight and energy metabolism, 10 affecting the two main causes of obesity:
energy acquisition and storage. 11 Moreover, the composition of the gut microbiota contributes to the insulin resistance 12 and the inflammatory state 13 characterizing obesity. High prepregnancy body mass index (BMI) and excessive weight gain during pregnancy are associated with aberrancies in the gut microbiota composition of the mother, 14 this acting as the inoculum for the development of the infant gut microbiota, 15 and thus carrying a potential to interfere with the healthy stepwise colonization of the infant gut. In a similar manner, breast milk, the composition of which also depends on the mother's nutritional and immunological state and gut microbiota composition, guides the compositional development of the infant gut microbiota. 16 Early
Bifidobacterium microbiota appear to protect against gut barrier dysfunction, 17 metabolic endotoxemia, insulin resistance 18 and obesity. 19 The composition of gut microbiota may thus be taken to represent a novel contributor to obesity above the traditional and well-known risk factors, excessive energy intake and sedentary behavior. On this basis, we here hypothesized that early modification of the gut microbial and immunological environment with probiotics will reduce the risk of overweight development and, thus, beneficially influence the child's early growth pattern. We therefore followed the growth of 113 children who were given probiotics or placebo perinatally in a double-blind, allergy prevention study until 10 years of age, with special attention to reducing the risk of allergic disease and the critical age for the development of overweight and the impact, if any, of this intervention on the child's BMI. The justification for the evaluation of overweight development and the importance of a healthy host-microbiome interaction in a population at high risk of allergic diseases, in addition to the probiotic intervention accomplished, is further supported by the similar environmental influences underlying obesity and allergic diseases, that is, a low-grade systemic inflammation. 20, 21 Subjects and methods
Subjects and study design
The original study population comprised 159 children participating in an ongoing, randomized, double-blind, prospective follow-up study of probiotics in allergic diseases (http://www.clinicaltrials.gov/ct/gui/show/NCT00167700), described in detail elsewhere. 22 In brief, children with at least one close relative (mother, father or sibling) with atopic dermatitis, allergic rhinitis or asthma were included. Mothers were recruited in antenatal clinics in Turku, Finland, and were randomized in a double-blind, placebocontrolled manner to receive 1 Â 10 10 colony-forming units of Lactobacillus rhamnosus GG (ATCC 53103, Valio Ltd, Helsinki, Finland) or placebo (microcrystalline cellulose) in capsules once a day for 4 weeks before expected delivery. After delivery, the capsule contents were given either to the mothers, if they were breastfeeding, or otherwise to the children mixed in water for 6 months. Both modes of administration have previously proved to be equally effective colonizers. 23 Written informed consent was obtained from the children's parents and the study design was approved by the Ethics Committee of the Hospital District of Southwest Finland.
As depicted in Figure 1 , of the 159 children enrolled, 113 completed the 10-year follow-up, these comprising the present study population.
Anthropometric measurements
After delivery, study visits were scheduled at the ages of 2 weeks; 3, 6, 12 and 24 months; and at 4 and 7 years. At every visit, a clinical examination was carried out and weights and heights measured. At the age of 10 years, weight and height data were collected from the parents; these measurements being taken by school health nurses. The BMI (in kg m
À2
) at 2, 4, 7 and 10 years of age was calculated as weight in kilograms divided by height in meters squared and approximated to one decimal place. BMI was chosen as an adequate and practical childhood obesity marker because of its strong correlation with other anthropometric indicators of obesity and central obesity. 24 Continued follow-up for 10 y n = 59
Continued the follow-up for 10 y n = 54 Figure 1 Flow chart of the procedure.
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Statistical analyses
The w 2 -test and analysis of variance (ANOVA) were used to compare the clinical characteristics between the study groups and between the overweight and normal-weight children. The Kruskall-Wallis test was used to test skewed continuous variables. The Breslow-Day interaction test was used to analyze the possible interactions between gender and probiotic intervention in overweight. Because no interaction was detected, the genders were combined in further analyses. Because of a significant association between birth weight and overweight, the analysis of covariance (ANCOVA), with birth weight as a covariate, was used to compare the BMI measurements between the study groups at the ages of 2, 4, 7 and 10 years. In addition, the ANCOVA for repeated measurements at the ages of 2, 4, 7 and 10 years, with birth weight as a covariate, was used to compare the study groups. In repeated measurement analysis, the missing BMI measure ments were imputed using linear interpolation, when appropriate. The BMI results are given as birth-weightadjusted means with 95% confidence intervals (95% CIs). Logistic regression analysis, including birth weight as a covariate, was used to test the effect of probiotics in overweight and obesity. The results are given as birthweight-adjusted odds ratios with 95% CIs. Data were analyzed using SPSS version 15.0 (SPSS Inc, Chicago, IL, USA). A P-value of o0.05 was considered statistically significant.
Results
There were no statistically significant differences between the study groups in the clinical characteristics ( Table 1) . The present population was found to be representative of the original population recruited (n ¼ 159) by means of the baseline clinical characteristics; 22 , respectively (P ¼ 0.600; Student's t-test). Altogether 25 children (22.1%), 17 (25.4%) boys and 8 (17.4%) girls, were overweight at the age of 10 years; 6 of them (5.3%), 4 (6.0%) boys and 2 (4.3%) girls, being obese. In this study population, mother's overweight was not a statistically significant risk for child's overweight at the age of 10 years (RR 1.92 (95% CI 0.94-3.96); P ¼ 0.127; w 2 -test). The genders were combined in further analyses, because no interaction was observed between the gender and the intervention in anthropometric measurements.
The clinical characteristics of the children who were overweight at the age of 10 years and those of normal weight children are shown in Table 2 . A statistically significant difference was observed in birth weight; the children who grew to be overweight were already heavier at birth than those who remained to be of normal weight. The mean BMIs of the children who were overweight at the age of 10 years were also constantly and increasingly higher at every measurement from the birth up to the age of 10 years compared with those of normal weight children, showing a statistically significant difference between these two groups at every measurement point (P ¼ o0.001, ANOVA for repeated measures) ( Figure 2 ). As depicted in Figure 2 , the initial phase of excessive weight gain initiated during fetal period and continued until 24-48 months of age and a second phase of excessive weight gain started after the age of 24-48 months, specifically in children already affected in the initial phase.
When evaluating the impact of the probiotic intervention on the child's BMI at each measurement point, the effect of intervention was shown as a tendency to reduce the birthweight-adjusted mean BMI at the age of 4 years (P ¼ 0.080, ANCOVA) (Table 3) . Moreover, the evaluation of BMIs adjusted for birth weight over the 10-year follow-up showed that the weight gain in those remaining normal weight was indistinguishable in the probiotic and placebo groups until 10 years of age, whereas in children who became overweight by the age of 10 years, the weight gain diverged between the intervention groups ( Figure 3) . The mean BMI of children who were overweight at the age of 10 years in the probiotic group (n ¼ 13) was constantly lower at every measurement from birth until 7 years of age compared with the children who were overweight at the age of 10 years in the placebo group (n ¼ 12), although no statistically significant differences between these groups were detected. The tendency was most pronounced at the age of 4 years (P ¼ 0.063, ANOVA for repeated measures). Probiotics and obesity in children R Luoto et al
Discussion
The results of this study bespeak differences in early growth patterns between children who become overweight by early adolescence and those who remain normal weight. The patterns leading to obesity are characterized as an initial phase setting in the perinatal period and lasts up to the age of 48 months, with a second phase starting after 4 years of age. The differences in the weight gain between the study groups during the initial phase, especially among the children who later became overweight, may be interpreted to indicate that the early but not the second phase of excessive weight gain could be modified by perinatal probiotic intervention. Among the childhood periods sensitive to the development of profound obesity and its metabolic sequelae, previously considered to be the time of adiposity rebound, 26 is that which occurs between the ages of 3 and 7 years and is regarded as the second period of rapid growth in body fat after infancy. Adolescence, conversely, represents the period in which the location of body fat changes in both boys and girls because of increasing production of androgens and estrogens, respectively. Overweight development during adolescence is also strongly linked to persistence of obesity, especially in girls. 27 The aforementioned ages during the life cycle are currently considered to be the most sensitive periods for the development of a child's individual eating and activity patterns, and thereby amenable for preventive and therapeutic measures to prevent overweight development. Previous interventions targeting the long-term regulation of energy balance programming have equally focused primarily on childhood environmental factors such as dietary patterns, physical activity, television viewing and sleep duration 28 and have thus far shown marginal efficacy.
The present results, which shows a higher birth weight in children later becoming overweight, tend to confirm previous epidemiological data indicating that even before childhood, the perinatal period and early infancy may lay the foundation for the development of bases for the child's immunological and metabolic phenotypes, a phenomenon called programming. 29, 30 Indeed, the fetus has an ability to respond to its nutritional environment by altering gene expression and cell numbers, selecting clones of cells and thereby guiding body size and metabolism. 31 Rapid weight gain in early infancy may reflect on the one hand a genetic predisposition to overweight, which is a programming initiated during the fetal period, or the mode of infant feeding, that is, formula feeding rather than breastfeeding, 32 or the early introduction of solid foods; 33 this being not the case in the present population. 22 Alternatively, and hence more likely, excessive weight gain during the first months of life may be a consequence of failure in establishing anti-inflammatory and tolerogenic responses to the initial environmental challenge that derives from indigenous gut microbes, thus creating a low-grade inflammatory state characteristic of obesity and metabolic disorders, 34 not to forget the impact of gut microbiota on the release of several energy balance-controlling gut hormones 35 and on the host metabolism. 10 Indeed, recent experimental studies have provided evidence pointing to the gut microbiota as an important contributor in the host energy harvest and nutrient metabolism. 10 The gut microbiota may bridge the indeterminate gap between food and weight by affecting the host metabolism through intestinal glucose absorption, lipogenesis children who were overweight and in those who were normal weight at the age of 10 years; P ¼ o0.001 at every measurement point, ANOVA for repeated measures. Probiotics and obesity in children R Luoto et al and fat deposition regulation. 11, 36 Moreover, a high-fat diet increases the intestinal gram-negative to gram-positive bacterial ratio and thus the plasma lipopolysaccharide concentration, which sets the tone for metabolic endotoxemia and thus triggers the low-grade inflammatory state affecting insulin sensitivity. 12, 13 Selective augmentation of Bifidobacterium species by prebiotic supplementation conversely, has been shown to be associated with improved glucose tolerance and decreased endotoxemia. 18, 37 The probiotic intervention in the present study specifically targeted the critical period of life when the composition of the gut microbiota and the immunological responsiveness are consolidated, aiming to beneficially influence the hostmicrobiome interaction. In addition to their capability to dampen the low-grade inflammatory state by stabilizing the permeability barrier of the intestine, 38 and consequently to reduce intestinal endotoxin levels, 39 probiotics may modify the intestinal milieu toward a nonobesitogenic environment by altering the fermentation of dietary polysaccharides. It is conceivable that the protection against early excessive weight gain provided by probiotics, as described in the present report, may have been mediated by both immunomodulatory pathways and energy harvest. The fact that the impact is limited to the first years of life may be a corollary to the breastfeeding-favored limited diversity of the early gut microbiota composition, which per se modulates the activity and thus the immunoregulatory effect of dendritic cells on the gut mucosa. 40 The obesity prevention programs based on bodyweight control by means of a balanced diet and physical exercise have so far achieved only limited success, possibly because of the lacking impact on the proinflammatory status characterizing obesity. We hypothesize here that perturbations in the individual gut microbiota structure, which is established during the initial phase of life, 15 contributes to the infants' at the ages 4, 7 and 10 years in children who were overweight and in those who were normal weight at 10 years of age is given separately in the probiotic and in the placebo group. Significance for mean difference between children who were overweight at 10 years of age is given separately in the probiotic and in the placebo group; P ¼ 0.115, 0.979, 0.501, 0.228, 0.133, 0.063, 0.555 and 0.700 at respective ages, ANOVA for repeated measures.
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Conclusion
The results of this present study may open up a novel potential area of interventions with an aim to fight against obesity and Western lifestyle diseases. The manipulation of early gut microbial communities might offer an applicable strategy to impact individual energy homeostasis and thus to prevent excessive body-weight gain, as the sensitivity to lifestyle interventions may depend on the individual gut microbiota composition. Our results also add weight to the hypothesis that interventions aiming to prevent obesity and its metabolic consequences later in life should be initiated as early as during the first months of life.
